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(1.6% v/s 0) and ISR (0.73% v/s 2.73%) rates were higher in the long
stent group which showed a trend towards significance. The total
stented length was higher in patients with events.
Conclusions: Angioplasty with a single long stent or overlapping
stents are two suitable options for PCI in long lesions. Both stra-
tegiesmay be considered complementary to each other and not as
mutually exclusive.
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Background: Contrast- Induced Nephropathy (CIN) has been
defined as a composite rise in the serum Cr level of more than 25%
or 0.5 mg/dl or more from baseline, with a reduction in urine
output to less than 0.5 ml/kg/hour for 6 hours after intravascular
administration of iodinated contrast. In patients undergoing
Percutaneous Coronary intervention (PCI), cases of CIN leading to
dialysis predicts catastrophic outcomes. Transient rises in the
creatinine (Cr) level relate directly to longer intensive care unit
and hospital ward stays translating to differences in mortality
after PCI.
Methods: The study was conducted after getting the approval
from the ethical committee of Narayana Medical College. All pa-
tients taken up for a PCI over a period of 1 year for any indication
were included in the study irrespective of the diagnosis & for
whom a minimum of 1 follow- up visit post- discharge was
available. Known patients of chronic kidney disease, irrespective
of whether they were already on dialysis treatment or not & pa-
tients who were lost to follow up after discharge were excluded
from the study.
Results: A total of 345 patients were included in the final analysis.
65 (18.84%) patients developed CIN as per the standard definition.
280 (80.16%) patients did not develop CIN. These 2 groups were
compared with each other for various parameters to analyze the
various correlations.
Conclusion: The predictors of CIN included elderly age, history of
smoking, history of non- steroidal anti- inflammatory drug
(NSAID) abuse, elevated C- reactive protein (CRP) levels, use of Gp
IIb/IIIa inhibitors peri- procedurally, presence of congestive car-
diac failure (CCF) & post- procedure blood transfusion. Mortality
was higher in the CIN groupwith the CIN risk score being higher in
the patients who developed CIN. The patients who developed CIN
had a significant loss in residual renal function at follow- up as
evaluated by estimated Glomerular Filtration Rate (eGFR).
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Background: Intravascular ultrasound (IVUS) is animportant
adjunct to angiography, providing new insights in the diagnosis
and therapy for coronary disease. Procedure related factors are
important contributor of both restenosis and thrombosis after
DES implantation. Stent under expansion ismost important factor
in DES failure.
Methods: This is retrospective single center observational study
was to evaluate impact of intravascular ultrasound (IVUS)-guided
percutaneous transluminal coronary angioplasty (PTCA) for the
treatment coronary lesions.We retrospectively evaluated a 45 le-
sions in 30 patients treated with IVUS-guided PTCA. The results
were compared with those of angiographic stentingin a matched
group of patients. Control population was matched in terms risk
factors, diagnosis, lengthof lesion, vessel anatomy.
The primary end points were the postprocedure measure of
minimal stent dimensions by angiography (diameter) and ultra-
sound (area, minimal diameter). The secondary end point was
independently adjudicated major cardiac events (death, MI, and
TVR) determined by follow-up at 12 months.
Results: The IVUS-guided group had a larger minimal lumen
diameter (3.0±0.4 versus 2.7±0.5 mm, P<0.001) by quantitative
coronary angiography and a larger minimal stent area
(MSA)(7.78±1.72 versus 7.06±2.13 mm2,) by quantitative coronary
ultrasound. Target vessel revascularization, defined as clinically
driven repeat interventional or surgical therapy of the index vessel
at 12month-follow-up, occurred significantly less frequently in the
IVUS-guided group (8.5% versus 15.3%, P<0.05; relative reduction of
44%). The average acute gain achieved was 1.84 ± 0.77 mm in IVUS
group , and 1.50 ± 0.44 mm in angiography group statistically sig-
nificant(P<0.001).One year follow-up MACE rates were lower in the
IVUS group than in the Angiography group (20% vs. 39%) [p< 0.05].
Conclusion: IVUS guidance for the treatment of coronary lesions
is associated with good acute outcome. IVUS guidance achieved
significantly larger minimal stent dimensions than that used
angiographic guidance alone. This difference was associated with
a 44% lower rate of TVR but no difference in mortality or MI.
Angiographic restenosis and follow-up MACE rates were signifi-
cantly lower with IVUS group.
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Background: Randomized controlled trials established the role of
BVS in the management of coronary artery disease (CAD). Data of
BVS in stable CAD and non ST elevation myocardial infarction/
acute coronary syndrome is convincing. There is limited data of
usage of BVS in ST elevation myocardial infarction (STEMI) man-
agement during transradial primary PCI. We report our initial
experience of usage of BVS in this clinical setting.
Methods: All patients of STEMI who were treated between June
2013 and 2014 with BVS were studied. STEMI was diagnosed as per
standard criteria. All patients were pre treated with chewable
aspirin 150 mg to 325 mg, ticagrelor 180 mg and atorvastatin 80
mg. Patients were shifted directly to catch lab from the ER. Radial
access was obtained. After the diagnostic angiogram, the infract
related artery was engaged with guiding catheter. The lesions
were crossed and predialated. The scaffolds were deployed at 6 to
12 atm pressure. The scaffolds were postdialated with
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